Tata Mutual Fund decreased its weightage in pharmaceuticals, engineering & capital goods and metals & mining space, while enhanced its exposure in information technology, cement & construction and automotive space.Gujarat Pipavav Port, LIC Housing Finance, NTPCwere the top sells, while IVRCL, Idea Cellular andJaiprakash Associates were the top buys.The study of the portfolio managed by Tata Mutual Fund for the month of October 2011 shows that, in the pharmaceuticals space, the fund sold Lupin, Torrent Pharmaceuticals and Ipca Laboratories, while it bought Divis Laboratories, Cipla and Sun Pharmaceutical Industries.In the engineering & capital goods pack, it sold Gujarat Pipavav Port, AIA Engineering and Cummins India, while it bought Larsen and Toubro, Crompton Greaves and BEML.(View - All Bulk Deals by Mutual Funds).In the metals & mining space, it sold Jindal Steel, Tata Steel, Coal India and Usha Martin and it exited from Maharashtra Seamless, while it bought Hindalco Industries, GMDC and Sterlite Industries and even introduced MOIL to its portfolio.On the buying side, the fund purchased Infosys, HCL Technologies and Tata Consultancy Services in the IT sector but sold Zenith Infotech, Hinduja Global Solutions and NIIT Technologies from the same sector. (Check out - Which sectors are attracting Fund Managers?)In the cement & construction space, the fund bought Jaiprakash Associates, Rain Commodities and added IVRCL to its portfolio, while it sold Simplex Infrastructures, Sadbhav Engineering and Supreme Infrastructure India.The fund bought Tata Motors (DVR), Tata Motors and Mahindra & Mahindra in the automotive segment, but sold Exide Industries and Amara Raja Batteries.
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac...
-
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma...
-
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th...
-
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y...
-
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after...
-
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ...
-
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment